Current Report Filing (8-k)
February 21 2018 - 4:42PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): February 21, 2018
Acadia Healthcare Company, Inc.
(Exact
Name of Registrant as Specified in Its Charter)
Delaware
|
|
001-35331
|
|
45-2492228
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
6100 Tower Circle, Suite 1000
(Address of Principal
Executive Offices)
(615) 861-6000
(Registrant's Telephone Number, including
Area Code)
Not Applicable
(Former Name or Former Address, if Changed
Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
⃞
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
⃞
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
⃞
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
⃞
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Indicate by
check mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§240.12b-2 of this chapter).
Emerging growth company
⃞
If an
emerging growth company, indicate by check mark if the registrant has
elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to
Section 13(a) of the Exchange Act.
⃞
Item 2.02 Results of Operations and Financial Condition.
On February 21, 2018, Acadia Healthcare Company, Inc. (“Acadia”) issued
a press release announcing, among other things, Acadia’s operating and
financial results for the fourth quarter and year ended December 31,
2017. The press release is furnished herewith as Exhibit 99 hereto and
is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
99 Press Release of Acadia Healthcare Company,
Inc., dated February 21, 2018.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
ACADIA HEALTHCARE COMPANY, INC.
|
|
|
|
|
Date:
|
February 21, 2018
|
|
By:
|
/s/ Christopher L. Howard
|
|
|
|
|
Christopher L. Howard
|
|
|
|
|
Executive Vice President and
|
|
|
|
|
General Counsel
|
EXHIBIT INDEX
Acadia Healthcare (NASDAQ:ACHC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Acadia Healthcare (NASDAQ:ACHC)
Historical Stock Chart
From Sep 2023 to Sep 2024